Avidity Biosciences (RNA) Stock Price
$31.12 0%
to add to portfolio
AI Score

-
Alternative
10 -
Fundamental
7 -
Technical
4
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Avidity Biosciences, AI stock picks, stock alerts and much more.
RNA AI Stock Analysis
AI stock analysis for RNA is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Avidity Biosciences (RNA) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Avidity Biosciences (RNA) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Avidity Biosciences (RNA), currently trading at $31.12, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About RNA

-
Avidity Biosciences, Inc.
-
Symbol
RNA
-
Market
NASDAQ
-
Industry
Biotechnology
-
Market Cap
3.7B
Similar Stocks
![]() |
Catalyst Pharmaceuticals CPRX |
$21.62 2% |
6 |
![]() |
Inovio Pharmaceuticals INO |
$2.24 0.9% |
2 |
![]() |
Moderna MRNA |
$35.53 5.3% |
4 |
![]() |
Anavex Life Sciences AVXL |
$8.35 3.8% |
6 |
![]() |
BridgeBio Pharma BBIO |
$36.85 0.1% |
6 |
News
RNA Alternative Data
Web Traffic
Avidity Biosciences receives an estimated 19083 monthly visitors to aviditybiosciences.com.
-
Web Traffic
19083
-
Change from Previous Month
61.4%
-
3 Month Change
9%
-
YoY Change
9%
News Mentions
Avidity Biosciences was mentioned 0 times in the news yesterday.
-
News Mentions
0
-
Daily Change
0%
-
1 Month Change
100%
-
3 Month Change
100%
Reddit Mentions
Avidity Biosciences has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
Twitter Followers
Avidity Biosciences has 712 Twitter Followers on its main Twitter (also known as X) account, which is up by 2% over the last month.
-
Twitter Followers
712
-
Daily Change
0%
-
1 Month Change
2%
-
3 Month Change
1.1%
LinkedIn Followers
21,916 are following Avidity Biosciences on LinkedIn, up by 6.4% over the last month.
-
LinkedIn Followers
21916
-
Daily Change
0.2%
-
1 Month Change
6.4%
-
3 Month Change
14.1%
Job Postings
Avidity Biosciences currenly has an estimated 43 open job postings, up by 34.4% over the last month.
-
Job Postings
43
-
Daily Change
4.4%
-
1 Month Change
34.4%
-
3 Month Change
24.6%
LinkedIn Employees
According to LinkedIn, Avidity Biosciences has 387 employees, up by 2.1% over the last month.
-
LinkedIn Employees
387
-
Daily Change
0%
-
1 Month Change
2.1%
-
3 Month Change
11.8%
Business Outlook
-
Business Outlook
82
-
Change from Previous Month
0%
-
3 Month Change
0%
-
YoY Change
0%
RNA Financials
RNA Key Metrics
-
Total Revenue
$2.3M
-
Net Income
-$80.4M
-
Earnings per Share
-$0.65
-
Free cash flow
-$67.3M
-
EBITDA
-$97.4M
-
EBITDA Ratio
-41.7055
-
Total Assets
$1.6B
RNA 2-year Revenue & Income
RNA 2-year Free Cash Flow
RNA Technicals
RNA SMA
RNA RSI
FAQ
What's the current price of Avidity Biosciences (RNA) Stock?
The price of an Avidity Biosciences (RNA) share is $31.12.
What's the market cap of Avidity Biosciences?
The current market cap of Avidity Biosciences is 3.7B.
Should I buy or sell RNA?
Multiple alternative data signals suggest that Avidity Biosciences stock could offer a buying opportunity at its current level, with a reasonable expectation for positive performance in the mid term.
Is Avidity Biosciences a good investment?
Based on an in-depth analysis that encompasses fundamentals, technical analysis, and alternative data insights, it appears to be a favorable time to consider investing in Avidity Biosciences stock. The bullish indicators suggest that Avidity Biosciences' growth prospects and market position may lead to a positive performance in the foreseeable future.
Is now a good time to buy Avidity Biosciences (RNA) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, it could be a favorable time to consider buying Avidity Biosciences stock, given the bullish outlook.
What are some stocks similar to Avidity Biosciences (RNA) that investors often compare it to?
Avidity Biosciences (RNA) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.
What is the forecast for Avidity Biosciences' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Avidity Biosciences' stock price to be around $33.92 in 2026. Starting from the current price of $31.12, this represents a 9% change in price, indicating a bullish outlook for the stock.
How to buy Avidity Biosciences (RNA) Stock?
Avidity Biosciences stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Avidity Biosciences shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.